AKT1 and ovarian cancer: Previous studies in AML, endometrial and ovarian cancer, showed an inhibition of PI3K/AKT which led to subsequent upregulation of PDCD4 and concomitant upregulation of cell cycle inhibitor, p27 [39,40,41].